PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Curiously, NAFLD patients homozygous for PNPLA3 risk allele c.444G presented significantly higher adiponectin (GG vs. CC, p < 0.05; GG vs. CG, p < 0.0001; Figure 3C).